F031 Managing Office Politics of Physicians, Patients and Personnel: Pick Your Poison
DESCRIPTION
The present economics of office/ hospital practice may have allowed for the insidious onset of seemingly out of control burnout, a toxic environment, with difficult people and situations threatening one’s personal ethics and joy of practice. Patients are treated as customers and healthy employee relations threatened by harassment claims and weaponized in social media. This interactive session will review scenarios dealing with management and navigation of the current state of office/hospital politics, focusing on the pitfalls and risks to dermatologists, their staff and patients. Participants will be given many practical strategies that can be immediately employed to reduce stresses.
LEARNING OBJECTIVES
Analyze and identify the issues and triggers for how office politics can lead to physician burnout as well as discuss many techniques to solve these stresses in our office.
Recognize the changes in patient expectations as customers and the impact this has on staff and clinic dynamics.
Utilize case discussion, audience participation, and sharing of experiences from various practice settings to evaluate pitfalls for physicians in navigating office politics, in order to rediscover the joys of practicing dermatology.
SCHEDULE
9:00 AM
Managing Office Politics of Physicians, Patients and Personnel
DIRECTOR
Joseph S. Eastern, MD, FAAD
SPEAKERS
Neal D. Bhatia, MD, FAAD
Francis W. Iacobellis, MD, FAAD
Steven Kenneth Shama, MD, MPH, FAAD
DISCLOSURES
Neal D. Bhatia, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria), Investigator(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Biofrontera AG – Consultant(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); Castle Biosciences – Consultant(Honoraria); Celldex – Investigator(Grants/Research Funding); Dermeleve – Consultant (1099 relationship)(Honoraria); Eli Lilly – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Honoraria); Johnson and Johnson Consumer Products Company – Investigator(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Consultant(Honoraria); LEO Pharma, US – Investigator(Grants/Research Funding); Novartis – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Practical Dermatology – Other(Honoraria); Sagimet Biosciences – Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Soligenix, Inc – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); VeraDermics Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);
Joseph S. Eastern, MD, FAAD
AbbVie – Investigator(Grants/Research Funding), Speaker(Honoraria);
Francis W. Iacobellis, MD, FAAD
Eli Lilly and Company – Speaker(Honoraria);
Steven Kenneth Shama, MD, MPH, FAAD
No financial relationships exist with ineligible companies.